AISF-SIMTI position paper on the appropriate use of albumin in patients with liver cirrhosis: a 2020 update
- PMID: 33370229
- PMCID: PMC7850931
- DOI: 10.2450/2020.0414-20
AISF-SIMTI position paper on the appropriate use of albumin in patients with liver cirrhosis: a 2020 update
Conflict of interest statement
PC has been speaker about this issue in symposia or webinars sponsored by Grifols SA, Octapharma SA and Kedrion Biopharma SpA and is collaborating with Octapharma SA industry for research in the field. PA has been a member of Sequana Medical AG Advisory Board and Ferring Advisory Board, and speaker in symposia sponsored by Kedrion Biopharma SpA. MB has been consultant and speaker for CSL Behring GmbH, Takeda, Grifols SA, and speaker in symposia sponsored by PPTA and Octapharma AG. No conflict of interest for all other Authors.
References
-
- Italian Association for the Study of the Liver (AISF) and Italian Society of Transfusion Medicine and Immunohaematology (SIMTI) AISF-SIMTI Position Paper: the appropriate use of albumin in patients with liver cirrhosis. Dig Liver Dis. 2016;48:4–15. - PubMed
-
- Caraceni P, Angeli P, Prati D, Bernardi M, Liumbruno GM, Bennardello F, Piccoli P, Velati C Italian Association for the Study of the Liver (AISF), Italian Society of Transfusion Medicine and Immunohaematology (SIMTI) AISF-SIMTI position paper: the appropriate use of albumin in patients with liver cirrhosis. Blood Transfus. 2016;14:8–22. - PMC - PubMed
-
- GRADE [internet] The GRADE system. [Accessed on 7/10/2020]. www.gradeworkinggroup.org/
-
- Bernardi M, Moreau R, Angeli P, et al. Mechanisms of decompensation and organ failure in cirrhosis: from peripheral arterial vasodilation to systemic inflammation hypothesis. J Hepatol. 2015;63:1272–84. - PubMed
-
- Bernardi M, Caraceni P. Novel perspectives in the management of decompensated cirrhosis. Nat Rev Gastroenterol Hepatol. 2018;15:753–64. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical